WithdrawnNCT00442923
"The Evaluation of Stimulant Withdrawal"
Medication studyAges 18–65United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- PortlandSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: July 1, 2007
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Aaron J. Janowsky
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00442923
- Official title
Show the full official title
Scientific Component IV: Pharmacotherapy to Prevent Methamphetamine Relapse
Recruitment & locations
WithdrawnPortland
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Aaron J. Janowsky.
Does this study involve medication?
Yes. The study involves medication, including Coreg.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
